n n n ‘. concat(e. i18n. t(“search. voice. recognition_retry”),’n
DUBLIN, Jan. 3, 2024 /PRNewswire/ — The “Fifth Annual Biomarkers and Companion Diagnostics Conference” has been added to the ResearchAndMarkets. com offering.
Leveraging Next-Gen Technologies Beyond Conventional Biomarker Drug Discovery
The emergence of the need for protection and efficacy of a drug administered to individual patients has made the other major diagnostics one of the most sought-after topics in the field of in vitro diagnostics. Increasing investment in other important diagnostics has raised questions about regulations and their complexities and spurred new trends in immuno-oncology, immunotherapies, knowledge interpretation, and unconventional clinical trial design.
More than 20 experts from academia and industry will provide their existing paintings on biomarkers, the latest updates on standards and regulatory approvals, the validation of cancer biomarkers for clinical applications, the challenging scenarios of NGS-based CDx, and the importance of Imaging biomarkers for accuracy. medicine.
Opportunity to expand long-lasting business relationships and networking opportunities with high-level colleagues. Take advantage of the opportunity to have your queries addressed by biomarker experts in a one-on-one session.
He facilitated networking sessions for quality interactions, as well as case studies of experts who have effectively created and developed a biomarker.
The fifth Annual Complementary Diagnostics and Biomarkers Conference, scheduled for March 7-8, 2024 in London, UK, would address the gaps between early progression of biomarkers and the level of commercialization of biomarkers.
This convention would also highlight case studies on leveraging emerging technologies in virtual biomarkers, precision medicine, and big data. As for the commercialization of biomarkers, leading industry and education experts would concentrate their case studies on advances in the field of other important diagnostics.
Keynote presentations would also make participants perceive problems similar to the clinical translation of biomarkers.
Reflexes:
Identification and qualification of biomarkers.
Biomarkers and personalized medicine
Assay development and validation
NGS and Developments in Biomarker Discovery
Commercialization of biomarkers in curative and CDx applications.
Speakers
Debora Souza Da Costa, Biological Sampling Operations Specialist, Roche
Stephanie Traub, Associate Director, Translational Biomarkers and Bioanalysis, UBC
Ron Wolbert, Associate Director, Bioanalytical Scientific Manager, Translational Biomarkers & Bioanalysis, UCB
Patrick Brossard, Director of Clinical Pharmacology, SOBI – Swedish Orphan Biovitrum AB
Smiths Lueong, Head, Early Detection and Biomarkers, The Cameroon Consortium for Translational Cancer Research
Christian Garde, Chief Scientific Officer, Bioinformatics, Evaxion Biotech A/S
Nathalie Steinhoff, Scientist, Cancer Immunotherapy, Numab Therapeutics AG
Shidong Jia, Founder, CEO, Predicine
Liying Yan, President, Scientist, EpigenDx
Robert Watson, Senior Clinical Professor, University of Oxford
Radha Krishnan, Executive Director and Clinical Pathology Lead, Merck
Jelmar Quist, Cancer Bioinformaticianist, King’s College London
Jessica Fowler, Director of Market Development, Roche
Aparna Duggirala, Senior Lecturer in Clinical Genetics, University of Derby
Christopher Peters, Senior Clinical Lecturer, Imperial College London
For more information about this conference visit https://www.researchandmarkets.com/r/j85161
About ResearchAndMarkets. com ResearchAndMarkets. com is the world’s leading source for foreign market research and market knowledge reports. We provide you with the latest knowledge on foreign and regional markets, key industries, larger companies, new products, and the latest trends.
Media Contact:
Research and MarketsLaura Wood, Senior [email protected] For E.S.T Office Hours Call +1-917-300-0470For U.S./CAN Toll Free Call +1-800-526-8630For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907Fax (outside U.S.): +353-1-481-1716
Show content: https://www. prnewswire. com/news-releases/biomarker-and-companion-diagnostics-annual-2-day-conference—london-united-kingdom-march-7-8th-2024- 302025425 . html
SOURCE Research & Markets